Amlin (LON: AML)‘s stock had its “underweight” rating reaffirmed by JPMorgan Chase in a research note issued on Thursday. They currently have a $5.85 (360 GBX) price target on the stock.

AML has been the subject of a number of other recent research reports. Analysts at Nomura reiterated a “neutral” rating on shares of Amlin in a research note to investors on Thursday, December 6th. They now have a $6.84 price target on the stock. Analysts at HSBC downgraded shares of Amlin to a “neutral” rating in a research note to investors on Monday, October 1st. They now have a $7.34 price target on the stock.

Amlin opened at 387.80 on Thursday. Amlin has a 52-week low of GBX 307.80 and a 52-week high of GBX 408.30. The company’s market cap is £1.919 billion.

Amlin plc is engaged in non-life insurance and reinsurance underwriting in the Lloyd’s market, Bermuda and Continental Europe.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.